# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations...
Discover the transformative effects of marijuana rescheduling on the cannabis industry, focusing on tax relief, financial impro...
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already in...
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decisi...
Employees at Cresco Labs Inc.'s Fall River, Massachusets-based cannabis cultivation operations have voted overwhelmingly t...
Cannabis giant Curaleaf Holdings is closing its previously announced acquisition of Northern Green Canada, a vertically integra...
Most cannabis industry observers realize that valuations and valuations multiples for the major MSOs are up Y/O/Y, spurred by t...
DeSantis blasted the cannabis companies that support cannabis legalization, all of whom happened to be at the Benzinga Cannabis...